The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Dosing & titration

The arithmetic of an intermediate dose between two label steps

MH
m.haddadTL2Regular18 May 2026#1

On the subject in the title: The arithmetic of an intermediate dose between two label steps Working notes rather than a conclusion.

I have read the maintained page on this and I still have a gap, so I am asking rather than guessing.

Context: retatrutide, 20 weeks in, currently at a dose I reached by the standard four-week steps. Everything below is my own record rather than anything a clinician told me.

The specific question is the one in the title. What I have already checked: the labelling summary on the relevant documentation page, the two most-linked topics in this subcategory, and my own notes from the last 9 weeks. What I could not find is whether the answer changes at higher doses or whether it is the same arithmetic throughout.

If the answer is "it depends", I would rather know what it depends on than be given a number.

17 likes 2mo
JH
j.habermannTL3Regular21 May 2026#2

Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you stay at an intermediate dose for years is not formally studied and extrapolation is the best available reasoning.

21 likes 2mo
CB
c.balogunTL2 Moderator23 May 2026 · edited#3

post #2 is right about the mechanism and I think understates the practical bit.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

0 likes 2mo
Moved from Reconstitution by KLindqvist. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

TopicParticipantsRepliesViewsActivity
Restarting after a long gap: what the labelling implies — the long version
Restarting after a long gap: what the labelling implies — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
OFDIBRMHF+12 17 2.4k 2mo
Dose numbers across compounds are not on the same scale
Dose numbers across compounds are not on the same scale — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I am asking…
BPISC 2 1.6k 9mo
Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
RMKCCLHETP+27 31 432 18mo
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept Reporting something rather than asking about it, in case the pattern…
BWSANTIRSS+7 11 26k 9mo
Reaching a dose and staying there for a year: a longitudinal note
Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…
RFNRHC 2 763 15mo

Related topics — sharing the tags dose reduction, semaglutide, missed dose

TopicParticipantsRepliesViewsActivity
Rotating between abdomen, thigh and upper arm: absorption differences — one year on
Rotating between abdomen, thigh and upper arm: absorption differences — one year on — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still…
ITTTBCSTN+82 102 24k just now
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept Reporting something rather than asking about it, in case the pattern…
BWSANTIRSS+7 11 26k 9mo
About the Semaglutide category
GLP-1 receptor agonist. Dosing, published trial data, tolerability, and formulation questions. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
TVJMRJGOMH 4 4.2k 11mo
Rotating between abdomen, thigh and upper arm: absorption differences
On the subject in the title: Rotating between abdomen, thigh and upper arm: absorption differences Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern…
WTNZED 2 3.5k 5mo
Drawing up with one needle and injecting with another
On the subject in the title: Drawing up with one needle and injecting with another Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go…
KFIDFIOCH+1 5 6.9k 1d